FLT3, NPM1, CEBPA AND TP53 MUTATIONS AT ACUTE PROMYELOCYTIC LEUKEMIA: PROGNOSTIC FACTORS AND CORRELATION WITH OTHER MARKERS WITHIN THE PATIENTS OF GOMEL REGION IN BELARUS

被引：0
|
作者：
Kozich, Z. [1 ]
Martinkov, V. [2 ]
Silin, A. [2 ]
Tropashko, I. [2 ]
机构：
[1] Republican Res Ctr Radiat Med & Human Ecol, Hematol, Gomel, BELARUS
[2] Republican Res Ctr Radiat Med & Human Ecol, Mol Genet, Gomel, BELARUS
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1700
引用
收藏
页码：685 / 685
页数：1
相关论文
共 50 条
  • [31] Prevalence and Effect Evaluation of FLT3 and NPM1 Mutations in Acute Myeloid Leukemia Patients in Eastern Algeria
    Ayachi, Ouarda Sariyah
    Rezgoun, Mohamed Larbi
    Sayitoglu, Muge
    Altindirek, Didem
    Erbilgin, Yucel
    Abadi, Noureddine
    Satta, Dalila
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2018, 28 (03): : 169 - 179
  • [32] De Novo Acute Myeloid Leukemia with DNMT3A, FLT3, and NPM1 Mutations
    Loghavi, S.
    Zuo, Z.
    Zhang, L.
    Stingo, F.
    Patel, K. P.
    Singh, R. R.
    Luthra, R.
    Routbort, M. J.
    Medeiros, J.
    Cortes, J. E.
    Ravandi-Kashani, F.
    Kantarjian, H. M.
    Khoury, J. D.
    LABORATORY INVESTIGATION, 2014, 94 : 359A - 359A
  • [33] De Novo Acute Myeloid Leukemia with DNMT3A, FLT3, and NPM1 Mutations
    Loghavi, S.
    Zuo, Z.
    Zhang, L.
    Stingo, F.
    Patel, K. P.
    Singh, R. R.
    Luthra, R.
    Routbort, M. J.
    Medeiros, J.
    Cortes, J. E.
    Ravandi-Kashani, F.
    Kantarjian, H. M.
    Khoury, J. D.
    MODERN PATHOLOGY, 2014, 27 : 359A - 359A
  • [34] Assessment of prognosis and minimal residual disease in acute myeloid leukemia based on the use of NPM1 gene mutations in patients of Gomel Region, Belarus
    Kozich, Z.
    Silin, A.
    Martinkov, V
    Tropashko, I
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 47 - 48
  • [35] Prognostic implications of NPM1 mutations and FLT3 internal tandem duplications in Egyptian patients with cytogenetically normal acute myeloid leukemia
    Shamaa, Sameh
    Laimon, Nabil
    Aladle, Doaa A.
    Azmy, Emad
    Elghannam, Doaa M.
    Salem, Dalia A.
    Taalab, Mona M.
    HEMATOLOGY, 2014, 19 (01) : 22 - 30
  • [36] Clinical features and prognostic significance of DNMT3A, FLT3, and NPM1 mutations in de novo acute myeloid leukemia patients
    Chen, Meiyu
    Zeng, Zhao
    Li, Xuewei
    Qin, Wei
    Cai, Xiaohui
    Chen, Suning
    Lu, Xuzhang
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2023, 45 (06) : 899 - 907
  • [37] PROGNOSTIC RELEVANCE OF FLT3/ITD, NPM1 AND CEBPA MUTATIONS IN ACUTE MYELOID LEUKAEMIA PATIENTS WITH NORMAL KARYOTYPE- THE SINGAPORE GENERAL HOSPITAL EXPERIENCE
    How, G-F
    Lim, L-C
    Wong, G-C
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 485 - 486
  • [38] Nucleophosmin mutation in Southeast Asian acute myeloid leukemia:: eight novel variants, FLT3 coexistence and prognostic impact of NPM1/FLT3 mutations
    Boonthimat, Chetsada
    Thongnoppakhun, Wanna
    Auewarakul, Chirayu U.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 (10): : 1565 - 1569
  • [39] A clinicopathological experience in acute myeloid leukemia: Effects of clinical data and status of FLT3, CEBPA and NPM1 on prognosis
    Yener, Emre
    Ozcan, Kerem
    Ongoren, Seniz
    Salihoglu, Ayse
    Demiroz, Ahu Senem
    AkI, Hilal
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2022, 65 (03) : 642 - 648
  • [40] NPM1 mutations are more stable than FLT3 mutations during the course of disease in patients with acute myeloid leukemia
    Palmisano, Michela
    Grafone, Tiziana
    Ottaviani, Emanuela
    Testoni, Nicoletta
    Baccarani, Michele
    Martinelli, Giovanni
    HAEMATOLOGICA, 2007, 92 (09) : 1268 - 1269
12345